TUCATINIB, TRASTUZUMAB, AND CAPECITABINE WITH STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES FROM HER-2 POSITIVE BREAST CANCER (TUTOR): A MULTICENTER PHASE 1 CLINICAL TRIAL

被引：0
|
作者：
Ahluwalia, M. S. [1 ,2 ]
Khosla, A. A. [1 ,2 ]
Ozair, A. [1 ]
Kotecha, R. R. [1 ,2 ]
McDermott, M. W. [1 ,2 ]
Mehta, M. P. [1 ,2 ]
Sandoval-Leon, A. C. [1 ]
Mahtani, R. [1 ,2 ]
Peereboom, D. M. [3 ]
机构：
[1] Baptist Hlth South Florida, Miami Canc Inst, Miami, FL USA
[2] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
10.1093/neuonc/noad137.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
JS06.5.A
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer: a phase 2 basket trial
    Okines, Alicia F. C.
    Curigliano, Giuseppe
    Mizuno, Nobumasa
    Oh, Do-Youn
    Rorive, Andree
    Soliman, Hatem
    Takahashi, Shunji
    Bekaii-Saab, Tanios
    Burkard, Mark E.
    Chung, Ki Y.
    Debruyne, Philip R.
    Fox, Jenny R.
    Gambardella, Valentina
    Gil-Martin, Marta
    Hamilton, Erika P.
    Monk, Bradley J.
    Nakamura, Yoshiaki
    Nguyen, Danny
    O'Malley, David M.
    Olawaiye, Alexander B.
    Pothuri, Bhavana
    Reck, Martin
    Sudo, Kazuki
    Sunakawa, Yu
    Van Marcke, Cedric
    Yu, Evan Y.
    Ramos, Jorge
    Tan, Sherry
    Bieda, Mark
    Stinchcombe, Thomas E.
    Pohlmann, Paula R.
    NATURE MEDICINE, 2025, : 909 - 916
  • [42] Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer (vol 12, pg 289, 2019)
    Murthy, Rashmi K.
    Loi, Sherene
    Okines, Alicia
    Paplomata, Elisavet
    Hamilton, Erika
    Hurvitz, Sara A.
    Lin, Nancy U.
    Borges, Virginia
    Abramson, Vandana
    Anders, Carey
    Bedard, Philippe L.
    Oliveira, Mafalda
    Jakobsen, Erik
    Bachelot, Thomas
    Shachar, Shlomit S.
    Mueller, Volkmar
    Braga, Sofia
    Duhoux, Francois P.
    Greil, Richard
    Cameron, David
    Carey, Lisa A.
    Curigliano, Giuseppe
    Gelmon, Karen
    Hortobagyi, Gabriel
    Krop, Ian
    Loibl, Sibylle
    Pegram, Mark
    Slamon, Dennis
    Palanca-Wessels, M. Corinna
    Walker, Luke
    Feng, Wentao
    Winer, Eric P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (06): : 586 - 586
  • [43] Tucatinib in the Treatment of HER2-positive Breast Cancer High Activity even in Patients with Brain Metastases
    Banys-Paluchowski, Maggie
    Krawczyk, Natalia
    ONKOLOGE, 2020, 26 (10): : 966 - 969
  • [44] Multi-Institutional Report of Trastuzumab-Deruxtecan and Stereotactic Radiosurgery for HER2+Breast Cancer Brain Metastases
    Khatri, V.
    Mestres-Villanueva, M.
    Doniparthi, A.
    Smith, D. B.
    Nakashima, J. Y.
    Zhao, D.
    Bryant, J. M.
    Mills, M. N.
    Oliver, D. E.
    Yu, H. H. M.
    Han, H. S.
    Soliman, H.
    Perlow, H. K.
    Upadhyay, R.
    Palmer, J. D.
    Beyer, S.
    Ahmedm, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E243 - E244
  • [45] Brain metastases in breast cancer patients overexpressing HER-2 and treated with trastuzumab: A single institution experience
    Quercia, S.
    Bernardi, A.
    Rosati, M.
    Cacciari, N.
    Massari, F.
    Sperandi, F.
    Zamagni, C.
    Martoni, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI9 - XI9
  • [46] Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer
    Bartsch, Rupert
    Rottenfusser, Andrea
    Wenzel, Catharina
    Dieckmann, Karin
    Pluschnig, Ursula
    Altorjai, Gabriela
    Rudas, Margaretha
    Mader, Robert M.
    Poetter, Richard
    Zielinski, Christoph C.
    Steger, Guenther G.
    JOURNAL OF NEURO-ONCOLOGY, 2007, 85 (03) : 311 - 317
  • [47] Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer
    Rupert Bartsch
    Andrea Rottenfusser
    Catharina Wenzel
    Karin Dieckmann
    Ursula Pluschnig
    Gabriela Altorjai
    Margaretha Rudas
    Robert M. Mader
    Richard Poetter
    Christoph C. Zielinski
    Guenther G. Steger
    Journal of Neuro-Oncology, 2007, 85 : 311 - 317
  • [48] The role of stereotactic radiosurgery in the treatment of brain Metastases from her-2-neu breast cancer
    MacAusland, S. G.
    Noren, G.
    Wazer, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S182 - S182
  • [49] Phase II trial of GDC0084 in combination with trastuzumab for patients with HER2-positive breast cancer brain metastases (BCBM)
    Leone, Jose P.
    Trippa, Lorenzo
    Milisits, Lindsey
    Andrews, Chelsea
    Ligibel, Jennifer
    Parsons, Heather
    Bi, Wenya L.
    Zhao, Jean
    Winer, Eric P.
    Lin, Nancy U.
    CANCER RESEARCH, 2020, 80 (04)
  • [50] Multicenter phase II trial of trastuzumab and capecitabine in patients with HER2 expressing metastasized pancreatic cancer
    Harder, J.
    Hofheinz, R.
    Moehler, M.
    Buechler, P.
    Kloeppel, G.
    Bitzer, M.
    Endlicher, E.
    Reinacher-Schick, A.
    Heinemann, V.
    Geissler, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 389 - 389
12345